Neuropilin-1 Interacts with Fibronectin-1 to Promote Epithelial–Mesenchymal Transition Progress in Gastric Cancer
出版年份 2020 全文链接
标题
Neuropilin-1 Interacts with Fibronectin-1 to Promote Epithelial–Mesenchymal Transition Progress in Gastric Cancer
作者
关键词
-
出版物
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 10677-10687
出版商
Informa UK Limited
发表日期
2020-10-20
DOI
10.2147/ott.s275327
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EMT is associated with an epigenetic signature of ECM remodeling genes
- (2019) Paul Peixoto et al. Cell Death & Disease
- Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT
- (2019) Yan Li et al. CANCER LETTERS
- EMT and Cancer: More Than Meets the Eye
- (2019) Rik Derynck et al. DEVELOPMENTAL CELL
- Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT
- (2019) Bifei Li et al. OncoTargets and Therapy
- IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling
- (2019) Ling Chen et al. ONCOLOGY REPORTS
- N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals
- (2019) Xiuping Huang et al. Nature Communications
- Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma
- (2019) Eric Morin et al. JOURNAL OF PATHOLOGY
- Increased Twist and ZEB2 expression in a cutaneous metastasis of high‐grade glioma
- (2019) Masaya Nagaishi et al. NEUROPATHOLOGY
- A PTAL-miR-101-FN1 Axis Promotes EMT and Invasion-Metastasis in Serous Ovarian Cancer
- (2019) Haihai Liang et al. Molecular Therapy-Oncolytics
- Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma
- (2018) Jing Meng et al. CANCER RESEARCH
- Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis
- (2018) Ling Cao et al. PeerJ
- Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
- (2017) Begum Erdogan et al. JOURNAL OF CELL BIOLOGY
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer
- (2016) Jingjing Wu et al. CARCINOGENESIS
- Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors
- (2016) Linhao Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors
- (2016) Jen-Chieh Lee et al. MODERN PATHOLOGY
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Transient SNAIL1 Expression Is Necessary for Metastatic Competence in Breast Cancer
- (2014) H. D. Tran et al. CANCER RESEARCH
- A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
- (2013) Julie Caramel et al. CANCER CELL
- Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro
- (2012) Zhanlong Shen et al. ACTA ONCOLOGICA
- ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer Cells
- (2012) Ying-Huan Dai et al. DIGESTIVE DISEASES AND SCIENCES
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started